Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Lauren C Seeberger & Robert A Hauser. (2015) Carbidopa levodopa enteral suspension. Expert Opinion on Pharmacotherapy 16:18, pages 2807-2817.
Read now
Read now
Livia Dézsi & László Vécsei. (2014)
Safinamide for the treatment of Parkinson's disease. Expert Opinion on Investigational Drugs 23:5, pages 729-742.
Read now
Read now
Adolfo Ramirez-Zamora & Eric Molho. (2014) Treatment of motor fluctuations in Parkinson’s disease: recent developments and future directions. Expert Review of Neurotherapeutics 14:1, pages 93-103.
Read now
Read now
Francesc Valldeoriola, Jaume Puig-Junoy & Ruth Puig-Peiró. (2013) Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study. Journal of Medical Economics 16:2, pages 191-201.
Read now
Read now
Robert A Hauser. (2012) IPX066: a novel carbidopa–levodopa extended-release formulation. Expert Review of Neurotherapeutics 12:2, pages 133-140.
Read now
Read now
Robert A. Hauser. (2011) Future Treatments for Parkinson's Disease: Surfing the PD Pipeline. International Journal of Neuroscience 121:sup2, pages 53-62.
Read now
Read now
H.H. Fernandez & P. Odin. (2011) Levodopa–carbidopa intestinal gel for treatment of advanced Parkinson’s disease. Current Medical Research and Opinion 27:5, pages 907-919.
Read now
Read now
Shadab Md, Shadabul Haque, Jasjeet Kaur Sahni, Sanjula Baboota & Javed Ali. (2011) New non-oral drug delivery systems for Parkinson's disease treatment. Expert Opinion on Drug Delivery 8:3, pages 359-374.
Read now
Read now
Angelo Antonini & Eduardo Tolosa. (2009) Apomorphine and levodopa infusion therapies for advanced Parkinson’s disease: selection criteria and patient management. Expert Review of Neurotherapeutics 9:6, pages 859-867.
Read now
Read now
Antonio Di Stefano, Piera Sozio, Antonio Iannitelli & Laura Serafina Cerasa. (2009) New drug delivery strategies for improved Parkinson's disease therapy. Expert Opinion on Drug Delivery 6:4, pages 389-404.
Read now
Read now
Miguel Coelho, Joaquim Ferreira, Mário Rosa & Cristina Sampaio. (2008) Treatment options for non-motor symptoms in late-stage Parkinson's disease. Expert Opinion on Pharmacotherapy 9:4, pages 523-535.
Read now
Read now
Articles from other publishers (30)
Trang N. N. Vo, Karen Frei & Daniel D. Truong. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
2993
3013
.
Pravika M, Jeevamma Jacob & Paul Joseph K. (2021) Design of model reference adaptive–PID controller for automated portable duodopa pump in Parkinson’s disease patients. Biomedical Signal Processing and Control 68, pages 102590.
Crossref
Crossref
Trang N. N. Vo, Karen Frei & Daniel D. Truong. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
21
.
Thomas Marshall, Amy Pugh, Angelyn Fairchild & Steven Hass. (2017) Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease. Value in Health 20:10, pages 1383-1393.
Crossref
Crossref
Amos D. Korczyn, Yacov Balash & Tanya Gurevich. 2017. International Encyclopedia of Public Health. International Encyclopedia of Public Health
409
415
.
L.P. Kotra & J. Park. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
439
473
.
Yasaman Kianirad & Tanya Simuni. (2016) Novel Approaches to Optimization of Levodopa Therapy for Parkinson’s Disease. Current Neurology and Neuroscience Reports 16:4.
Crossref
Crossref
Krishe Menezes, Lawrence W. Elmer & Robert A. Hauser. 2016. Parkinson's Disease. Parkinson's Disease
83
92
.
. 2016. Parkinson's Disease. Parkinson's Disease
1
92
.
Oluwadamilola O Ojo & Hubert H Fernandez. (2015) Levodopa/carbidopa intestinal gel: an effective formulation for the management of advanced Parkinson's disease. Future Neurology 10:3, pages 191-201.
Crossref
Crossref
Philippe Huot. 2014. Levodopa-Induced Dyskinesia in Parkinson's Disease. Levodopa-Induced Dyskinesia in Parkinson's Disease
147
169
.
Jean-François Daneault, Benoit Carignan, Abbas F Sadikot, Michel Panisset & Christian Duval. (2013) Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?. BMC Medicine 11:1.
Crossref
Crossref
Liang Ye, Xiaolin Guan, Jingwei Tian, Jianzhao Zhang, Guangying Du, Xin Yu, Pengfei Yu, Xiaobo Cen, Wanhui Liu & Youxin Li. (2013) Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in SD rats. Food and Chemical Toxicology 56, pages 81-92.
Crossref
Crossref
Thomas Müller, Teus van Laar, David R. Cornblath, Per Odin, Fabian Klostermann, Francisco J. Grandas, Georg Ebersbach, Peter P. Urban, Francesc Valldeoriola & Angelo Antonini. (2013) Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery. Parkinsonism & Related Disorders 19:5, pages 501-507.
Crossref
Crossref
Jingwei Tian, Guangying Du, Liang Ye, Xin Yu, Jianzhao Zhang, Hongbo Wang, Pengfei Yu, Fenghua Fu, Wanhui Liu, Youxin Li, Xiaobo Cen & Xiaolin Guan. (2013) Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in Cynomolgus monkeys. Food and Chemical Toxicology 52, pages 143-152.
Crossref
Crossref
S. E. Pålhagen, N. Dizdar, T. Hauge, B. Holmberg, R. Jansson, J. Linder, D. Nyholm, O. Sydow, M. Wainwright, H. Widner & A. Johansson. (2012) Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease. Acta Neurologica Scandinavica 126:6, pages e29-e33.
Crossref
Crossref
Thomas Müller, Manfred Gerlach, Moussa B.H. Youdim & Peter Riederer. 2012. Neurobiology of Psychiatric Disorders. Neurobiology of Psychiatric Disorders
477
490
.
Ulrich Schwabe & Dieter PaffrathUlrich Schwabe. 2012. Arzneiverordnungs-Report 2012. Arzneiverordnungs-Report 2012
819
832
.
Tobias Hahn, Sebastian Kozerke, Werner Schwizer, Michael Fried, Peter Boesiger & Andreas Steingoetter. (2011)
Visualization and quantification of intestinal transit and motor function by real-time tracking of
19
F labeled capsules in humans
. Magnetic Resonance in Medicine 66:3, pages 812-820.
Crossref
Crossref
Ronald F. Pfeiffer. 2011. Parkinson's Disease. Parkinson's Disease
257
273
.
R. Carron, V. Fraix, C. Maineri, E. Seigneuret, B. Piallat, P. Krack, P. Pollak, A. L. Benabid & Stéphan Chabardès. (2010) High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review. Journal of Neural Transmission 118:6, pages 915-924.
Crossref
Crossref
Rüdiger Hilker, Angelo Antonini & Per Odin. (2010) What is the best treatment for fluctuating Parkinson’s disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?. Journal of Neural Transmission 118:6, pages 907-914.
Crossref
Crossref
Alessandro StefaniMariangela PierantozziGiacomo KochSalvatore GalatiPaolo Stanzione. (2010) Therapy for dyskinesias in Parkinson’s disease patients. Future Neurology 5:2, pages 277-299.
Crossref
Crossref
Angelo Antonini, K. Ray Chaudhuri, Pablo Martinez-Martin & Per Odin. (2010) Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinsonʼs Disease. CNS Drugs 24:2, pages 119-129.
Crossref
Crossref
Sara Varanese, Zoe Birnbaum, Roger Rossi & Alessandro Di Rocco. (2010) Treatment of Advanced Parkinson's Disease. Parkinson's Disease 2010, pages 1-9.
Crossref
Crossref
Jack J. Chen, David M. Swope, Khashayar Dashtipour & Kelly E. Lyons. (2012) Transdermal Rotigotine: A Clinically Innovative Dopamine‐Receptor Agonist for the Management of Parkinson's Disease. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29:12, pages 1452-1467.
Crossref
Crossref
Ruth Djaldetti, Nirit Lev & Eldad Melamed. (2009) Lesions outside the CNS in Parkinson's disease. Movement Disorders 24:6, pages 793-800.
Crossref
Crossref
Angelo Antonini. (2009) Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease. Journal of Movement Disorders 2:1, pages 4-9.
Crossref
Crossref
F. Raudino, P. Garavaglia, C. Pianezzola, G. Riboldazzi, S. Leva, M. Guidotti & G. Bono. (2009) Long-term experience with continuous duodenal levodopa–carbidopa infusion (Duodopa): report of six patients. Neurological Sciences 30:1, pages 85-86.
Crossref
Crossref
A.D. Korczyn. 2008. International Encyclopedia of Public Health. International Encyclopedia of Public Health
10
17
.